
pmid: 20705195
Urinary tract infection (UTI) is the most common urologic disorder and one of the most common conditions for which physicians are consulted. Patients at increased risk for UTI include women; diabetics; the immunocompromised; and those with anatomic abnormalities, impaired mobility, incontinence, advanced age, and instrumentation. Antibiotic therapy aims to relieve symptoms and prevent complications such as pyelonephritis and renal scarring. Distinguishing asymptomatic bacteriuria from a UTI can be difficult, especially in those with comorbidities. Most experts do not recommend screening for UTI, except in the first trimester of pregnancy.
Male, Cross Infection, Primary Health Care, Pyelonephritis, Kidney, Anti-Bacterial Agents, Diabetes Complications, Radiography, Immunocompromised Host, Pregnancy, Recurrence, Urinary Tract Infections, Humans, Female, Pregnancy Complications, Infectious, Spinal Cord Injuries, Ultrasonography
Male, Cross Infection, Primary Health Care, Pyelonephritis, Kidney, Anti-Bacterial Agents, Diabetes Complications, Radiography, Immunocompromised Host, Pregnancy, Recurrence, Urinary Tract Infections, Humans, Female, Pregnancy Complications, Infectious, Spinal Cord Injuries, Ultrasonography
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 32 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
